Early clinical trial results of Favipiravir for Covid-19 promising : Glenmark

Indian pharma major Glenmark has stated that its phase three clinical trials using antiviral drug Favipiravir for Covid-19 patients is showing early p

from Business Line - Companies https://ift.tt/3fzAltg